Generic Exclusivity Waiver Policy Could Change, FDA Suggests
Executive Summary
The generic drug exclusivity forfeiture provisions in the Medicare Modernization Act raise "interesting questions" about whether ANDA first-filers should be permitted to waive or relinquish their exclusivity, FDA Associate Chief Counsel Elizabeth Dickinson said